Ads
related to: moderna stock
Search results
US nears deal to fund Moderna's bird flu vaccine trial, FT reports
Reuters via Yahoo News· 15 hours agoModerna told Reuters it was in discussions with the government on advancing its vaccine candidate,...
Salesforce, Kohl's and Agilent fall premarket; Foot Locker, Moderna rise By Investing.com
Investing.com· 8 hours agoSalesforce, Kohl's and Agilent fall premarket; Foot Locker, Moderna rise
The Zacks Analyst Blog Highlights NVIDIA, Constellation Energy, Micron Technology, Moderna and...
Zacks via Yahoo Finance· 6 hours agoModerna is a commercial-stage pharmaceutical company primarily focused on discovering and developing...
The Moderna Selloff Gains Steam. An Analyst Has a Few Theories Why.
Barrons.com· 1 day agoWhat began Tuesday as a puzzling dip in shares of the biotech Moderna accelerated into a larger...
Moderna (MRNA) Stock Outperformed Industry YTD: Here's Why
Zacks via Yahoo Finance· 2 days agoDespite the declining top line, shares of Moderna MRNA continue to soar thanks to its encouraging...
...Robinhood Holdings Amid Bitcoin Dip, Keeps Selling Moderna Stock — Buys Palantir And AMD Shares -...
Benzinga· 17 hours agoOn Wednesday, Ark Invest, led by the influential investor Cathie Wood, executed notable trades...
Moderna and this solar name are among the most overbought stocks after a record-setting week
CNBC· 6 days agoIt may be time for investors to trim positions in overbought names after the stock market reached...
A company insider recently sold 1,296 shares of Moderna Inc [MRNA]. Should You Sale? – Knox Daily
Knox Daily· 13 hours agoThe buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Moderna ...
The Zacks Analyst Blog Highlights NVIDIA, Constellation Energy, Micron Technology, Moderna and...
Zacks· 15 hours ago(CEG Quick QuoteCEG - Free Report) , Micron Technology (MU Quick QuoteMU - Free Report) , Moderna Inc. (MRNA Quick QuoteMRNA - Free Report) and Qualcomm Inc. (QCOM Quick QuoteQCOM ...
Should You Buy This Stock After a Regulatory Setback? | The Motley Fool
The Motley Fool· 4 days agoThe past two-and-a-half years have been rough for Moderna (MRNA 1.58%). The company is developing...